Real-Time PCR for Dihydrofolate Reductase Gene Single-Nucleotide Polymorphisms in Plasmodium vivax Isolates

Author:

Brega Sara1,de Monbrison Frédérique12,Severini Carlo3,Udomsangpetch Rachanee4,Sutanto Inge5,Ruckert Paul6,Peyron François17,Picot Stéphane12

Affiliation:

1. E.A.3732, Parasitologie, Mycologie Médicale et Pathologie Exotique, Faculté de Médecine, Université Claude Bernard

2. Service de Parasitologie, Mycologie Médicale et Maladies Tropicales, Hôpital E. Herriot, Hospices Civils de Lyon

3. Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità, Rome, Italy

4. Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand

5. Department of Parasitology, Faculty of Medicine, University of Indonesia, Jakarta

6. Deutsche Gesellschaft für Technische Zusammenarbeit (GTZ), GTZ Sis-Kes Kupang, NTT, Indonesia

7. Service de Parasitologie et Maladies Tropicales, Hôpital de la Croix-Rousse, Lyon, France

Abstract

ABSTRACT Mutations in the dhfr gene of Plasmodium vivax ( pvdhfr ) are associated with resistance to the antifolate antimalarial drugs. Polymorphisms in the pvdhfr gene were assessed by hybridization probe technology on the LightCycler instrument with 134 P. vivax -infected blood samples from Turkey ( n = 24), Azerbaijan ( n = 39), Thailand ( n = 16), Indonesia ( n = 53), and travelers ( n = 19). Double mutations (S58R and S117N) or quadruple mutations (F57L/I, S58R, T61M, and S117N) in the pvdhfr genes were found in all Thai samples (100%). pvdhfr mutant-type alleles were significantly more common in samples from travelers (42%) than in those from patients from Indonesia (5%). Surprisingly, the pvdhfr single - mutation allele (S117N) was identified at a high frequency in parasites from Turkey and Azerbaijan (71 and 36%, respectively), where sulfadoxine-pyrimethamine is not recommended for the treatment of P. vivax malaria by the World Health Organization and the Malaria National Programs.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3